Rejuvel Bio-Sciences, Inc. (NUUU) Financial Statements (2024 and earlier)

Company Profile

Business Address CHASE BANK BUILDING 150 SE 2ND AVE
MIAMI, FL 33131
State of Incorp. FL
Fiscal Year End December 31
Industry (SIC) 519 - Miscellaneous Non-durable Goods (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2015
MRQ
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 405121
Cash and cash equivalents 405121
Inventory, net of allowances, customer advances and progress billings 571125
Inventory 571125
Other current assets 2 
Prepaid expense and other current assets24
Other undisclosed current assets 7750
Total current assets: 5385300
Noncurrent Assets
Property, plant and equipment 624026
Intangible assets, net (including goodwill) 1622
Intangible assets, net (excluding goodwill) 1622
Other undisclosed noncurrent assets (26)(20)(12)
Total noncurrent assets: 522116
TOTAL ASSETS: 105106315
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 459344194
Other undisclosed accounts payable and accrued liabilities 459344194
Derivative instruments and hedges, liabilities 49350276
Deferred revenue and credits 3  
Due to related parties 777789
Other undisclosed current liabilities 350436 
Total current liabilities: 9381,207559
Noncurrent Liabilities
Other undisclosed liabilities   224
Total liabilities: 9381,207782
Equity
Equity, attributable to parent (833)(1,101)(467)
Common stock 50117117
Additional paid in capital 1,274586505
Accumulated deficit (2,158)(1,805)(1,089)
Total equity: (833)(1,101)(467)
TOTAL LIABILITIES AND EQUITY: 105106315

Income Statement (P&L) ($ in thousands)

9/30/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Revenues 94528
Cost of revenue (83)(27)(4)
Gross profit: 11254
Operating expenses (814)(653)(766)
Other undisclosed operating income 7359984
Operating loss: (69)(530)(678)
Nonoperating expense
(Investment Income, Nonoperating)
 (267)  
Interest and debt expense 99(196)(153)
Loss from continuing operations: (237)(726)(831)
Loss before gain (loss) on sale of properties: (237)(726)(831)
Net loss: (237)(726)(831)
Other undisclosed net income (loss) attributable to parent (116)11(3)
Net loss available to common stockholders, diluted: (353)(716)(834)

Comprehensive Income ($ in thousands)

9/30/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Net loss: (237)(726)(831)
Comprehensive loss, net of tax, attributable to parent: (237)(726)(831)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: